Photodynamic Therapy With S-1 in the Patients With Unresectable Type III or IV Cholangiocarcinoma: A Prospective Randomized Trial With Open Label Control.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Porfimer sodium
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 30 Jan 2014 Status changed from recruiting to completed, based on publication of results.
- 30 Jan 2014 Results published in the European Journal of Cancer.
- 11 Mar 2013 Planned number of patients changed from 55 to 45 as reported by ClinicalTrials.gov.